Digital Pharmacist Bought by K1 Investment Management

Digital Pharmacist Bought by K1 Investment Management

K1 Investment Management, LLC, a leading investment firm focusing on high-growth enterprise software companies globally, has purchased Digital Pharmacist Inc. for $100 million. Digital Pharmacist provides HIPAA-compliant web, text, mobile and voice applications for pharmacies to automate refill requests and reminders, and to automate communication with patients. Over 7,500 pharmacies currently use the platform. With the investment from K1, Digital Pharmacist will scale its operations to meet the increasing demand for its platform. It will develop new products to further enhance the patient-pharmacist experience. Digital Pharmacist’s management team and employees will continue to operate... Read More »
Tabula Rasa Builds its Patient Engagement Platform

Tabula Rasa Builds its Patient Engagement Platform

Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) has acquired PrescribeWellness, a cloud-based patient engagement solutions company. Based in Irvine, California, PrescribeWellness facilitates collaboration between more than 10,000 pharmacies with patients, payers, providers and pharmaceutical companies. It provides patient services such as medication home-delivery, appointment scheduling, Medicare plan reviews and more. The acquisition cost Tabula $150 million, roughly 5x PrescribeWellness’ 2018 revenue of $29 million. This acquisition supports its goals to expand medication risk mitigation programs in community pharmacies and provide them with clinical revenue opportunities beyond... Read More »
Australian Pharmaceutical Industries closes 2018 with pharmacy deal

Australian Pharmaceutical Industries closes 2018 with pharmacy deal

Australian Pharmaceutical Industries (ASX: API) closed out 2018 by announcing it acquired Sigma Healthcare Ltd (ASX: SIG), a wholesale and distribution service for pharmacies. With $2.96 million of reported revenue in FY2018, Sigma also owns several pharmacy retail brands in Australia such as Amcal Max, DDS, Amcal, and Guardian. The deal was valued at $524.9 million (AUD $727 million), which is a 46.5% premium to Sigma’s one-month volume weighted average share price of $0.34 at the close of trading on December 13. Australian Pharmaceutical Industries (API) offers wholesale product delivery, retail services, marketing programs, and business advisory services. Not only will API gain... Read More »